ADXN 7.9 (+0.51%)
US00654J1079BiotechnologyBiotechnology

Addex Therapeutics (ADXN) Stock Highlights

7.9 | +0.51%
2024-12-21 07:39:06
Addex Therapeutics Ltd is a biopharmaceutical company. The company operates through single segment which includes developing drugs to improve human health. It is focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. In addition, it is also engaged in the development of the dipraglurant and ADX71441 program. The companys geographical area of operations includes Switzerland and Europe.

Statistics

Range Today
7.84 7.9
Volume Today 12.1K
Range 1 Year
5.39 27.9
Volume 1 Year 22.41M
Range 3 Year
5 139.2
Volume 3 Year 35.65M
Range 10 Year
5 750.4
Volume 10 Year 36.08M

Highlights

Market Capitalization 12.49M (micro)
Floating Shares 34.24M
Current Price 7.9
Price To Earnings -0.56
Price To Revenue 1.2K
Price To Book 81.78
Earnings Per Share -19.18
Payout Ratio 0%

Performance

Latest +0.51%
1 Month +1.02%
3 Months -18.56%
6 Months -1%
1 Year +40.32%
3 Years -94.18%
5 Years -96.51%
10 Years -96.51%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.